News | Press Releases

---

December 4, 2019

Canon Medical’s Alphenix Platform at the Forefront of Helping Hospitals Prepare for the Future of Interventional Medicine

Canon Medical to Showcase High-Definition Image Resolution Technology at RSNA 2019

CHICAGO, Dec. 4, 2019 – Since its launch in 2018, Canon Medical’s Alphenix platform has helped clinicians think beyond the traditional boundaries of interventional procedures, with its streamlined workflow, dose optimization and improved image resolutions. For example, the specialized team of neuroendovascular surgeons at Kaleida Health Gates Vascular Institute, a leading international stroke and cardiac care facility in Buffalo, N.Y., have successfully utilized the platform’s biplane technology with the world’s first High-Definition Flat Panel Detector to advance neurovascular treatment options for patients. This innovative technology enables clinicians to see fine details clearly and precisely during complex interventional procedures, enabling them to prioritize workflow, clinical insight and patient care.

“The high-definition imaging capabilities are most beneficial during the critical stage when we are utilizing high magnification imagery to deploy a complex intravascular device such as stents, coils, flow diverters and endovascular flow disruptors,” said Adnan Siddiqui, MD, PhD, director of neurological stroke services at Gates Vascular Institute and associate professor of neurosurgery at the University at Buffalo. “There’s nothing that comes close to the ability to visualize these implements than with Canon Medical’s high-definition technology.”

Canon Medical’s Hi-Def Detector, available on the Alphenix Biplane and Alphenix Core + systems, is the world’s first high-definition detector for resolving fine details.

“By enabling the visualization of intricate anatomy with the highest level of resolution available* in the angiography market, our Hi-Def Detector offers clinicians the ability to perform minimally invasive neurovascular therapy with clear images to see fine details, enabling them to prioritize clinical decisions and patient outcomes,” said Kristin Jones, acting managing director, Vascular Business Unit, Canon Medical Systems USA, Inc. “The Alphenix platform is an example of Canon Medical’s commitment to providing next generation technology that our customers need to treat their patients safely, accurately and confidently.”

Canon Medical is showcasing the Alphenix family of products and Alphenix Hi-Def Detector technology at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, December 1 – 6, 2019 (Booth #1933, South Hall).

About Canon Medical Systems USA, Inc.

Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Canon Medical Systems’ website at https://us.medical.canon.

About Canon Medical Systems Corporation

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound, Vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.

At Canon Medical, we work hand in hand with our partners – our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life. For more information, visit the Canon Medical website: https://global.medical.canon.

*76 micron resolution

Alphenix, Illuvis and Made for Life are trademarks of Canon Medical Systems Corporation.